Correlation of cumulative exposure to metabolic factors with progression of lower extremity arterial disease in type 2 diabetic patients

Mei YOU; Yushuang LIU; Ping YANG; Li LI; Ruomei YANG; Qiang LI; Qing ZHOU; Yingsha LI; Zhiming ZHU; Zhencheng YAN

doi:10.16016/j.2097-0927.202106201

您当前的位置：

首页 >

文章列表页 >

Correlation of cumulative exposure to metabolic factors with progression of lower extremity arterial disease in type 2 diabetic patients

Clinical Medicine | 更新时间：2026-01-09

- Correlation of cumulative exposure to metabolic factors with progression of lower extremity arterial disease in type 2 diabetic patients
- Journal of Army Medical University Vol. 44, Issue 5, Pages: 469-475(2022)
- 作者机构：
  
  400042 重庆，陆军特色医学中心高血压内分泌科，代谢性血管病重庆市重点实验室，全军高血压代谢病中心，重庆市高血压研究所
- 作者简介：
- 基金信息：
  
  the General Program of Natural Science Foundation of Chongqing(CSTC2019jcyj-msxmX0152);the Project of Army Medical Center of PLA(2019CXLCB008)
- DOI：10.16016/j.2097-0927.202106201
  CLC： R181.32;R543.5;R587.2
- Received：25 June 2021，
  
  Revised：2021-09-17，
  
  Published：15 March 2022
- 稿件说明：
移动端阅览
Mei YOU, Yushuang LIU, Ping YANG, et al. Correlation of cumulative exposure to metabolic factors with progression of lower extremity arterial disease in type 2 diabetic patients[J]. Journal of Army Medical University, 2022, 44(5): 469-475.
DOI：

Mei YOU, Yushuang LIU, Ping YANG, et al. Correlation of cumulative exposure to metabolic factors with progression of lower extremity arterial disease in type 2 diabetic patients[J]. Journal of Army Medical University, 2022, 44(5): 469-475. DOI： 10.16016/j.2097-0927.202106201.

摘要

目的

探讨累积代谢因素暴露值与2型糖尿病患者下肢血管病变(lower extremity arterial disease，LEAD)进展的相关性。

方法

回顾性分析2013年1月至2021年3月于本科连续3年入院的157例2型糖尿病患者资料，根据随访期间踝肱指数(ankle brachial index

ABI)下降情况，分为LEAD进展组(

=63)和LEAD无进展组(

=94)，采用独立样本

检验或非参数检验对比分析2组间人口学基本特征、实验室检查的基础值和累积暴露值，采用COX回归模型分析LEAD进展的独立危险因素。

结果

与LEAD无进展组比较，LEAD进展组年龄更大，糖尿病和高血压病程更长，糖尿病脑血管、心血管和周围神经病变患病率更高，调脂药、抗血小板药用药率更高；LEAD进展患者的基础ABI、终末ABI和累积ABI均更低，基础收缩压、舒张压均更高，累积收缩压、舒张压、总胆固醇、空腹血糖、糖化血红蛋白、超敏C反应蛋白、微量白蛋白、尿白蛋白肌酐比值暴露值均更高(

0.05)。多元COX回归分析提示糖尿病脑血管病变(

=2.448，95%

：1.436~4.173，

=0.001)、糖尿病周围神经病变(

=2.237，95%

：1.312~3.812，

=0.003)、累积收缩压暴露值(

=1.128，95%

：1.067~1.193，

0.001)、累积尿白蛋白肌酐比值暴露值(

=1.015，95%

：1.006~1.025，

=0.001)为LEAD进展的独立危险因素。

结论

糖尿病脑血管病变、糖尿病周围神经病变、高累积收缩压暴露值和高尿白蛋白肌酐比值暴露值是2型糖尿病患者LEAD进展的独立危险因素。

Abstract

Objective

To investigate the correlation between cumulative exposure to metabolic factors and progression of lower extremity arterial disease (LEAD) in patients with type 2 diabetes mellitus (T2DM).

Methods

Clinical data of 157 T2DM patients who were hospitalized to our department for 3 consecutive years from January 2013 to March 2021 were collected and retrospectively analyzed. According to decline in ankle brachial index (ABI) during follow-up

the patients were divided into LEAD progression group (

=63) and LEAD non-progression group (

=94). Independent sample

-test or non-parametric test was adopted to compare and analyze the clinical baseline characteristics

basic values of laboratory tests and cumulative exposure values of metabolic factors between the 2 groups; Cox regression model was employed to explore the independent risk factors for LEAD progression.

Results

As compared with the LEAD non-progression group

the LEAD progression group had older age

longer history of diabetes and hypertension

higher prevalence of diabetic cerebrovascular disease

cardiovascular disease and peripheral neuropathy

and higher usages of medications

including lipid-regulating and anti-platelet drugs. In the LEAD progression patients

the baseline

terminal and cumulative ABI were lower

while the systolic blood pressure (SBP) and diastolic blood pressure (DBP) were higher (

0.05)

and the cumulative exposure values of SBP

DBP

total cholesterol

fasting plasma glucose

hemoglobin Alc

hypersensitive C-reactive protein

microalbumin and urinary albumin creatine ratio (UACR) were all elevated when compared with the LEAD non-progression group (

0.05). Multivariate Cox regression analysis indicated that diabetic cerebrovascular diseases (

=2.448

95%

: 1.436~4.173

=0.001)

peripheral neuropathy (

=2.237

95%

: 1.312~3.812

=0.003)

cumulative exposure value of SBP (

=1.128

95%

: 1.067~1.193

0.001) and that of UACR (

=1.015

95%

: 1.006~1.025

=0.001) were independent risk factors for LEAD progression.

Conclusion

Diabetic cerebrovascular disease

peripheral neuropathy

and increased cumulative exposure values of SBP and UACR are independent risk factors for progression of LEAD in T2DM patients.

关键词

Keywords

references

朱大龙, 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版)[J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398. DOI: 10.3760/cma.j.cn115791-20210221-00095.

ZHU D L, Diabetes Branch of Chinese Medical Association. Guideline for the prevention and treatment of type 2 diabete mellitus in China(2020 Edition)[J]. Chin J Endocrinol Metab, 2021, 37(4): 311-398. DOI: 10.3760/cma.j.cn115791-20210221-00095.

CRIQUI M H, ABOYANS V. Epidemiology of peripheral artery disease[J]. Circ Res, 2015, 116(9): 1509-1526. DOI: 10.1161/CIRCRESAHA.116.303849.

CRIQUI M H, MATSUSHITA K, ABOYANS V, et al . Lower extremity peripheral artery disease: contemporary epidemiology, management gaps, and future directions: a scientific statement from the American heart association[J ] . Circulation, 2021, 144(9): e171-e191. DOI: 10.1161/cir.0000000000001005.

NORMAN P, DAVIS W, BRUCE D, et al . Peripheral arterial disease and risk of cardiac death in type 2 diabetes: the Fremantle Diabetes Study[J ] . Diabet Care, 2006, 29(3): 575-580. DOI: 10.2337/diacare.29.03.06.dc05-1567

ADLER A I, STEVENS R J, NEIL A, et al . UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes[J ] . Diabetes Care, 2002, 25(5): 894-899. DOI: 10.2337/diacare.25.5.894.

ESHCOL J, JEBARANI S, ANJANA R M, et al . Prevalence, incidence and progression of peripheral arterial disease in Asian Indian type 2 diabetic patients[J ] . J Diabetes Complicat, 2014, 28(5): 627-631. DOI: 10.1016/j.jdiacomp.2014.04.013.

FOWKES F G, ABOYANS V, FOWKES F J, et al . Peripheral artery disease: epidemiology and global perspectives[J ] . Nat Rev Cardiol, 2017, 14(3): 156-170. DOI: 10.1038/nrcardio.2016.179.

ZEMAITIS P, LIU K, JACOBS D R, et al . Cumulative systolic BP and changes in urine albumin-to-creatinine ratios in nondiabetic participants of the multi-ethnic study of atherosclerosis[J ] . Clin J Am Soc Nephrol, 2014, 9(11): 1922-1929. DOI: 10.2215/cjn.02450314.

CARDOSO C R L, SALLES G C, SALLES G F. Prognostic importance of on-treatment clinic and ambulatory blood pressures in resistant hypertension: a cohort study[J]. Hypertension, 2020, 75(5): 1184-1194. DOI: 10.1161/HYPERTENSIONAHA.120.14782.

YAMAGISHI S I, MATSUI T. Role of hyperglycemia-induced advanced glycation end product(AGE) accumulation in atherosclerosis[J]. Ann Vasc Dis, 2018, 11(3): 253-258. DOI: 10.3400/avd.ra.18-00070.

冉兴无, 贾伟平, 王贵强. 中国糖尿病足防治指南(2019版)(Ⅰ)[J]. 中华糖尿病杂志, 2019, (2): 92-108. DOI: 10.3760/cma.j.issn.1674-5809.2019.02.004.

RAN X W, JIA W P, WANG G Q. Chinses guideline on prevention and managment of diabetic foot(2019 Edition)[J]. Chin J Diabet Mellit, 2019, (2): 92-108. DOI: 10.3760/cma.j.issn.1674-5809.2019.02.004.

UGWU E, ANYANWU A, OLAMOYEGUN M. Ankle brachial index as a surrogate to vascular imaging in evaluation of peripheral artery disease in patients with type 2 diabetes[J]. BMC Cardiovasc Disord, 2021, 21(1): 10. DOI: 10.1186/s12872-020-01821-6.

BUSO G, ABOYANS V, MAZZOLAI L. Lower extremity artery disease in patients with type 2 diabetes[J]. Eur J Prev Cardiol, 2019, 26(2_suppl): 114-124. DOI: 10.1177/2047487319880044.

BIRD C E, CRIQUI M H, FRONEK A, et al . Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing[J ] . Vasc Med, 1999, 4(1): 15-21. DOI: 10. 1177/1358836x9900400103.

CRIQUI M H, NINOMIYA J K, WINGARD D L, et al . Progression of peripheral arterial disease predicts cardiovascular disease morbidity and mortality[J ] . J Am Coll Cardiol, 2008, 52(21): 1736-1742. DOI: 10.1016/j.jacc.2008.07.060.

CARDOSO C R L, MELO J V, SANTOS T R M, et al . Traditional and non-traditional risk factors for peripheral artery disease development/progression in patients with type 2 diabetes: the Rio de Janeiro type 2 diabetes cohort study[J ] . Cardiovasc Diabetol, 2021, 20(1): 54. DOI: 10.1186/s12933-021-01249-y.

MOHAMMEDI K, WOODWARD M, HIRAKAWA Y, et al . Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes[J ] . Diabetes Care, 2016, 39(10): 1796-1803. DOI: 10.2337/dc16-0588.

SUWANNASRISUK P, SATTANON S, TABUREE W, et al . Prevalence and predictors of peripheral arterial disease determined by ankle brachial index in diabetes population treated within primary care services in a non-urban area of lower northern Thailand[J ] . Diab Vasc Dis Res, 2020, 17(6): 1479164120966997. DOI: 10.1177/1479164120966997.

BECKMAN J A, DUNCAN M S, DAMRAUER S M, et al . Microvascular disease, peripheral artery disease, and amputation[J ] . Circulation, 2019, 140(6): 449-458. DOI: 10.1161/circulationaha.119.040672.

GARIMELLA P S, IX J H, KATZ R, et al . Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the multi-ethnic study of atherosclerosis(MESA)[J ] . Am J Kidney Dis, 2015, 65(1): 33-40. DOI: 10.1053/j.ajkd.2014.05.014.

余颖, 陆泽元, 张华清, 等. 2型糖尿病患者尿白蛋白与肌酐的比值和下肢动脉病变的相关性研究[J]. 中国糖尿病杂志, 2017, 25(7): 610-614. DOI: 10.3969/j.issn.1006-6187.2017.07.007.

YU Y, LU Z Y, ZHANG H Q, et al . Study of the relationship betwen urinealbumin-to-creatinineratio and peripheral artery disease in type 2 diabetes melitus[J ] . Chin J Diabetes, 2017, 25(7): 610-614. DOI: 10.3969/j.issn.1006-6187.2017.07.007.

黄凌宁, 杨立勇, 严孙杰, 等. 2型糖尿病患者踝臂血压指数和尿白蛋白与肌酐比值的相关性[J]. 中华高血压杂志, 2011, 19(11): 1075-1079. DOI: 10.16439/j.cnki.1673-7245.2011.11.032.

HUANG L Q, YANG L Y, YAN S J, et al . Relationship betwen ankle-brachial index and urinary albumin to creatinine ratio in patients with type 2 diabetes mellitus[J ] . Chin J Hypertens, 2011, 19(11): 1075-1079. DOI: 10.16439/j.cnki.1673-7245.2011.11.032.

SCHIFFRIN E L, LIPMAN M L, MANN J F. Chronic kidney disease: effects on the cardiovascular system[J]. Circulation, 2007, 116(1): 85-97. DOI: 10.1161/circulationaha.106.678342.

LUCZAK M, FORMANOWICZ D, PAWLICZAK E, et al . Chronic kidney disease-related atherosclerosis-proteomic studies of blood plasma[J ] . Proteome Sci, 2011, 9: 25. DOI: 10.1186/1477-5956-9-25.

HONG X, HUANG L, ZHANG Y, et al . Stronger association of albuminuria with the risk of vascular complications than estimated glomerular filtration rate in type 2 diabetes[J ] . Kidney Blood Press Res, 2021, 46(5): 550-562. DOI: 10.1159/000515163.

WANG X, MUKHERJEE B, PARK S. Associations of cumulative exposure to heavy metal mixtures with obesity and its comorbidities among U.S. adults in NHANES 2003-2014[J]. Environ Int, 2018, 121(Pt 1): 683-694. DOI: 10.1016/j.envint.2018.09.035.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Risk factors for stroke-associated pneumonia after endovasular treatment in acute anterior circulation ischemic stroke patients

Impact of molecular heterogeneity of NPM1 mutations on prognosis of acute myeloid leukemia: a clinical report of 86 cases

Efficacy and prognostic factors of second transurethral resection for non-muscle-invasive bladder cancer

Predictive value of TyG-BMI, AIP, and postprandial glucose excursion for sarcopenia in patients with type 2 diabetes mellitus

Incidence and risk factors of acute renal injury after Stanford type A aortic dissections

Related Author

CAI Zhengwei

ZHANG Xiaoge

GAO Yang

ZUO Meng

DAI Lin

QIN Yujie

WANG Yu

YU Xiaoda

Related Institution

Department of Neurology， First Affiliated Hospital， Army Medical University （Third Military Medical University）

Chongqing Center for Disease Control and Prevention

the First Clinical Medical College of Lanzhou University, the First Hospital of Lanzhou University

Department of Hematology, the First Hospital of Lanzhou University

Department of Urology， Army Medical Center of PLA/Daping Hospital of Third Military Medical University

⁰